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Darier-White disease (DWD) is an autosomal-
dominant skin disease characterized by warty
keratotic papules and plaques in a primarily
seborrheic distribution. Vegetating papules, erosions,
or blisters may sometimes be present. Other
findings may include varieties of nail abnormalities,
‘‘cobblestoning’’ of the oral mucosa, filiform kerato-
derma on the palms and soles, and hyperkeratosis
verruciformis of Hopf. DWD has an unpredictable
clinical course, andpatientsmaypresentwith variable
extents of involvement and diverse morphologies at
different body areas.1,2 Neuropsychiatric abnormal-
ities and immunologic aberrations have been re-
ported in association with DWD.3,4 Clinical subtypes
reported to date include hypertrophic,5 vesicobul-
lous, hypopigmented, cornifying, zosteriform or
linear, and comedonal variants.6
DWD has recently been linked to mutations in the
SERCA2 gene, which encodes the calcium ATPase
pump in the sarcoendoplasmic reticulum. Alterations
in calcium signaling cause aberrant keratinocyte dif-
ferentiation. The result is characteristic dyskeratosis
follicularis, demonstrated by the presence of typical
dyskeratotic cells, such as, corps ronds and grains.
Treatments may include emollients, topical reti-
noids, topical steroids, and intermittent courses of
oral antibiotics and systemic retinoids.
We present a unique case of DWD showing
overlap between several clinical subtypes of the
disease with a 20-year course and fatal outcome.CASE REPORT
We present a 44-year-old man with a unique
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tmail.com.otherwise unremarkable, and he had no family
member with any remarkable diseases. Symptom
onset was during infancy, and the disease was first
diagnosed in 1995when the patient was 27 years old.
Data regarding symptoms during infancy were not
available, yet according to the patient, mild acne was
present in a seborrheic distribution since 6 months of
age, with summertime exacerbations. He was treated
intermittently with systemic retinoids and from 1995
to 2014 suffered multiple complications including
several epidsodes of sepsis, Kaposi varicelliform
eruption, frequent local infection episodes with
multiple microorganisms (ie, Staphylococcus aureus
and Morganella morganii), and an atypical
Mycobacterium cutaneous infection in 2005. All
infections were treated successfully with systemic
or local antibiotics.
During 2013, the disease reached its peak, man-
ifested by a widespread erythema involving 95% of
his body surface area, thousands of hypertrophic
warty keratotic papules, and plaques accompanied
by multiple cysts and nodules. Numerous giant
comedones were observed on his face and trunk.
Severe macerations of the skin accompanied by
severe fetor were noticed on physical examination
in addition to leoninelike facies and diffuse palmo-
plantar keratoderma (Figs 1 and 2). Furthermore,
extreme cachexia and tachycardia were present
(Fig 3). Neuropsychiatric evaluation was normal.
An additional skin biopsy obtained from the trunkJAAD Case Reports 2015;1:41-3.
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Fig 1. Progressive deterioration of 20 years’ duration. The patient in 1999, 2005, and 2013.
Fig 2. The 2013 DWD episode. Note the filiform keratoderma.
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grains, and suprabasal clefts (Fig 4); Periodic
acideSchiff staining was negative. Laboratory tests
found anemia, leukocytosis, and hypoalbuminemia.
Skin cultures were positive for S aureus,Mmorganii,
and Streptococcus group G. Blood cultures were
positive for S aureus. Fungal infection was excluded
by direct smear and cultures, tissue culture, and
polymerase chain reaction. HIV serology was nega-
tive, and polymerase chain reaction test results for
herpes simplex type 1 and 2 and varicella zoster,
done in multiple skin lesions, were negative. Blood
absorption indexes including blood iron, folic acid,
transferrin, and vitamin D were extremely low.
Findings on immune function tests, including
neutrophil phagocytosis, chemotaxis, and super ox-
ide production, were within normal limits. Flow
cytometry test results were unremarkable. The pa-
tient refused to undergo any invasive gastrointestinal
evaluation, yet computed tomography enterography
was normal. Spinal and chest radiographs werenormal, and transthoracic cardiac echo test ruled
out endocarditis. Genetic test for the 3-base deletion
in exon 2 of leucine (41st residue, N-terminal)
reported recently for comedonal DWD was
negative.7
The patient was treated with prolonged intrave-
nous broad-spectrum antibiotics, high-dose oral iso-
tretinoin (Roacutane, Hoffmann-La Roche Ltd, Basel,
Switzerland), up to 2 mg/kg at its peak, and topical
keratolytic therapy. Although the infections re-
sponded well, the cutaneous disease had only partial
response to therapy. The patientwas discharged from
our department. Ten months later, the patient pre-
sented to the intensive care unit with severe sepsis
accompanied by severe hypoglycemia and wide-
spread erythema and died 2 days after admission.
DISCUSSION
This case shows several features that establish
DWD diagnosis: multiple warty keratotic papules
and plaques, obvious seborrheic predilection, and
Fig 3. DWD: giant comedons, 2005; cachexia and erythema, 2005; compared with 2013.
Fig 4. Skin biopsy photomicrograph shows evidence of
keratotic plug, dyskeratosis, and corps ronds (arrows).
(H&E stain, original magnification: 3360).
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keratosis, corps ronds, and grains. Nevertheless, this
case is unique in its extreme cutaneous manifesta-
tions and progressive course. The patient shows the
classic complications associated with DWD: multiple
local infections, sepsis, and erythroderma. However,
no evidence for immunologic or neuropsychiatric
aberrations was observed. Clinically, this case ex-
hibits several features that may overlap with the
comedonal and hypertrophic variant of DWD, yet
genetic analysis for the reported mutation in come-
donal DWD was negative. The predominant pres-
ence of comedones prompted isotretinoin treatment
and, indeed, clinical response while on treatmentduring admission was satisfactory, although it was
observed to be partial. The progressive fatal deteri-
oration could be explained in this case by either poor
adherence, tachyphylaxis to treatment, or malab-
sorption, as gastrointestinal involvement could not
be definitely ruled out.
We present an extremely atypical case of DWD,
with overlap between hypertrophic and comedonal
subtypes and fatal outcome. Negative genetic find-
ings for the reported mutation in comedonal DWD
may suggest the presence of other mutations yet to
be discovered.
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